Jaguar Health (JAGX) Receivables (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Receivables data on file, last reported at $280000.0 in Q1 2026.

• On a quarterly basis, Receivables fell 79.84% year-over-year to $280000.0 in Q1 2026; TTM through Mar 2026 was $280000.0, a 79.84% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, up 3.1% from the prior year.
• Receivables for Q1 2026 stood at $280000.0, down from $1.6 million in the prior quarter.
• Over the last five years, Receivables for JAGX reached as high as $2.5 million in Q3 2022 and fell as low as $280000.0 in Q1 2026.
• Historically, Receivables has averaged $1.6 million across 5 years, with a median of $1.6 million in 2024.
• Across the five-year window, Receivables advanced 18.7% in 2024 and sank 79.84% in 2026, its largest moves.
• Year by year, Receivables stood at $1.8 million in 2022, then climbed by 11.37% to $2.0 million in 2023, then slipped by 19.87% to $1.6 million in 2024, then gained by 1.75% to $1.6 million in 2025, then slumped by 82.81% to $280000.0 in 2026.
• Per Business Quant data, the three most recent Receivables figures were $280000.0 in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.